NME3 Human

Non-Metastatic Cells 3 Human Recombinant
Cat. No.
BT19653
Source
Escherichia Coli.
Synonyms
Protein expressed in non-metastatic cells 3, DR-nm23, Nucleoside diphosphate kinase C, NDPKC,  NDK 3, NDP kinase 3, EC 2.7.4.6, NM23H3, KIAA0516, NDPK-C, NM23-H3, c371H6.2, NDP kinase C, nucleoside diphosphate kinase 3, nm23-H3.
Appearance
Sterile Filtered clear solution.
Purity
Greater than 95% as determined by SDS-PAGE.
Usage
THE BioTeks products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
Shipped with Ice Packs
In Stock

Description

NME3 Human Recombinant produced in E.Coli is a single, non-glycosylated polypeptide chain containing 169 amino acids (22-169.a.a) and having a molecular mass of 19.1kDa.
NME3 is fused to a 20 amino acid His-tag at N-terminus & purified by proprietary chromatographic techniques.

Product Specs

Introduction
NME3, a potential suppressor of metastasis, exhibits significantly lower expression in highly metastatic cells compared to cells with reduced metastatic potential. This protein plays a crucial role in nucleoside triphosphate synthesis and contributes to apoptosis induction and hematopoiesis. NME3 expression is predominantly observed during the initial stages of myeloid differentiation in highly purified CD34+ cells.
Description
Recombinant human NME3 protein, expressed in E. coli, is a single, non-glycosylated polypeptide chain consisting of 169 amino acids (22-169.a.a) with a molecular weight of 19.1 kDa. This protein features a 20 amino acid His-tag fused at the N-terminus and undergoes purification using proprietary chromatographic techniques.
Physical Appearance
Clear solution, sterile filtered.
Formulation
The NME3 protein solution is provided at a concentration of 0.5 mg/ml in a buffer comprising 20 mM Tris-HCl (pH 8.0), 0.1 M NaCl, 2 mM DTT, and 50% glycerol.
Stability
For short-term storage (2-4 weeks), keep at 4°C. For extended storage, freeze at -20°C. Adding a carrier protein (0.1% HSA or BSA) is recommended for long-term storage. Avoid repeated freeze-thaw cycles.
Purity
Purity exceeding 95% as determined by SDS-PAGE analysis.
Synonyms
Protein expressed in non-metastatic cells 3, DR-nm23, Nucleoside diphosphate kinase C, NDPKC,  NDK 3, NDP kinase 3, EC 2.7.4.6, NM23H3, KIAA0516, NDPK-C, NM23-H3, c371H6.2, NDP kinase C, nucleoside diphosphate kinase 3, nm23-H3.
Source
Escherichia Coli.
Amino Acid Sequence
MGSSHHHHHH SSGLVPRGSH MERTFLAVKP DGVQRRLVGE IVRRFERKGF KLVALKLVQA SEELLREHYA ELRERPFYGR LVKYMASGPV VAMVWQGLDV VRTSRALIGA TNPADAPPGT IRGDFCIEVG KNLIHGSDSV ESARREIALW FRADELLCWE DSAGHWLYE.

Product Science Overview

Structure and Production

NME3 is a single, non-glycosylated polypeptide chain consisting of 169 amino acids, with a molecular mass of approximately 19.1 kDa . The recombinant form of NME3 is typically produced in Escherichia coli (E. coli) and is fused to a 21 amino acid His tag at the N-terminus to facilitate purification . The protein is purified using proprietary chromatographic techniques to ensure high purity, often greater than 95% as determined by SDS-PAGE .

Biological Functions

NME3 is involved in several critical biological functions:

  1. Nucleoside Triphosphate Synthesis: NME3 is essential for the synthesis of nucleoside triphosphates, which are the building blocks of DNA and RNA .
  2. Apoptosis Induction: NME3 has a role in the induction of apoptosis, the process of programmed cell death, which is vital for maintaining cellular homeostasis and eliminating damaged or cancerous cells .
  3. Hematopoiesis: NME3 is expressed during the early stages of myeloid differentiation of highly purified CD34+ cells, indicating its importance in the formation of blood cells .
Role in Cancer

NME3 is considered a potential metastasis suppressor. Studies have shown that NME3 levels are lower in highly metastatic cells compared to cells with lower metastatic potential . This suggests that NME3 may play a role in inhibiting the spread of cancer cells, making it a target of interest for cancer research and potential therapeutic interventions .

Stability and Storage

The recombinant NME3 protein is typically formulated in a solution containing 20mM Tris-HCl buffer (pH 8.0), 0.1M NaCl, 2mM DTT, and 50% glycerol . For short-term storage, it is recommended to keep the protein at 4°C if it will be used within 2-4 weeks. For long-term storage, the protein should be frozen at -20°C, and it is advisable to add a carrier protein (0.1% HSA or BSA) to prevent degradation .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.